484 related articles for article (PubMed ID: 11686419)
1. The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast.
Lanz MJ; Eisenlohr C; Llabre MM; Toledo Y; Lanz MA
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):283-8. PubMed ID: 11686419
[TBL] [Abstract][Full Text] [Related]
2. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.
Busse W; Wolfe J; Storms W; Srebro S; Edwards L; Johnson M; Bowers BW; Rogenes PR; Rickard K
J Fam Pract; 2001 Jul; 50(7):595-602. PubMed ID: 11485708
[TBL] [Abstract][Full Text] [Related]
3. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
Fritscher LG; Rodrigues MT; Zamel N; Chapman KR
Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
[TBL] [Abstract][Full Text] [Related]
4. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
[TBL] [Abstract][Full Text] [Related]
5. Asthma treatment with inhaled corticosteroids versus antileukotrienes: what exhaled nitric oxide studies do and do not tell us.
Dykewicz MS
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):257-60. PubMed ID: 11686416
[No Abstract] [Full Text] [Related]
6. Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma.
Bleecker ER; Welch MJ; Weinstein SF; Kalberg C; Johnson M; Edwards L; Rickard KA
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1123-9. PubMed ID: 10856145
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
8. Effects of 2 weeks of treatment with fluticasone propionate 100 mcg b.d. by comparison with zafirlukast 20 mg b.d. on bronchial hyper-responsiveness in patients with mild to moderate asthma.
Westbroek J; Pasma HR
Respir Med; 2000 Feb; 94(2):112-8. PubMed ID: 10714415
[TBL] [Abstract][Full Text] [Related]
9. A comparison of short-term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthma.
Nathan RA; Bleecker ER; Kalberg C;
Am J Med; 2001 Aug; 111(3):195-202. PubMed ID: 11530030
[TBL] [Abstract][Full Text] [Related]
10. Effect of fluticasone 250 microg/salmeterol 50 microg and montelukast on exhaled nitric oxide in asthmatic patients.
Gelb AF; Taylor CF; Shinar CM; Gutierrez CA; Zamel N
Can Respir J; 2008; 15(4):193-8. PubMed ID: 18551200
[TBL] [Abstract][Full Text] [Related]
11. Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age.
Creticos P; Knobil K; Edwards LD; Rickard KA; Dorinsky P
Ann Allergy Asthma Immunol; 2002 Apr; 88(4):401-9. PubMed ID: 11991558
[TBL] [Abstract][Full Text] [Related]
12. Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy.
Kim KT; Ginchansky EJ; Friedman BF; Srebro S; Pepsin PJ; Edwards L; Stanford RH; Rickard K
Ann Allergy Asthma Immunol; 2000 Nov; 85(5):398-406. PubMed ID: 11101185
[TBL] [Abstract][Full Text] [Related]
13. Randomized, Double-Blind, Crossover, Clinical-End-Point Pilot Study to Examine the Use of Exhaled Nitric Oxide as a Bioassay for Dose Separation of Inhaled Fluticasone Propionate.
Weiler JM; Sorkness CA; Hendeles L; Nichols S; Zhu Y
J Clin Pharmacol; 2018 Apr; 58(4):448-456. PubMed ID: 29193247
[TBL] [Abstract][Full Text] [Related]
14. Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children.
Ghiro L; Zanconato S; Rampon O; Piovan V; Pasquale MF; Baraldi E
Eur Respir J; 2002 Sep; 20(3):630-4. PubMed ID: 12358339
[TBL] [Abstract][Full Text] [Related]
15. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma.
van Rensen EL; Straathof KC; Veselic-Charvat MA; Zwinderman AH; Bel EH; Sterk PJ
Thorax; 1999 May; 54(5):403-8. PubMed ID: 10212103
[TBL] [Abstract][Full Text] [Related]
16. Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype.
Lipworth BJ; Dempsey OJ; Aziz I; Wilson AM
Am J Med; 2000 Aug; 109(2):114-21. PubMed ID: 10967152
[TBL] [Abstract][Full Text] [Related]
17. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
Lee DK; Haggart K; Currie GP; Bates CE; Lipworth BJ
Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
[TBL] [Abstract][Full Text] [Related]
18. Effect of the addition of montelukast to inhaled fluticasone propionate on airway inflammation.
O'Sullivan S; Akveld M; Burke CM; Poulter LW
Am J Respir Crit Care Med; 2003 Mar; 167(5):745-50. PubMed ID: 12480610
[TBL] [Abstract][Full Text] [Related]
19. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function.
Lee DK; Bates CE; Currie GP; Cowan LM; McFarlane LC; Lipworth BJ
Ann Allergy Asthma Immunol; 2004 Sep; 93(3):253-8. PubMed ID: 15478385
[TBL] [Abstract][Full Text] [Related]
20. Comparison of exhaled nitric oxide to spirometry during emergency treatment of asthma exacerbations with glucocorticoids in children.
Lanz MJ; Leung DY; White CW
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):161-4. PubMed ID: 10071519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]